AXS-05 Phase II Trial on Smoking Behavior
Completed · Phase 2
Conditions studied: Smoking Cessation, Smoking, Cigarette, Nicotine Dependence
In brief
This research study is designed with the purpose of evaluating a new drug, combination Dextromethorphan-Bupropion (AXS-05), for its effects on smoking behavior.
Key facts
- Study ID
- NCT03471767
- Run by
- James Davis
- People needed
- 58
- Starts
- 2018-03-25
- Expected to finish
- 2019-03-31
- Last updated by the study team
- 2022-12-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- Duke Center for Smoking Cessation — Durham, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.